Shuo Huang

1 ta ish

Carisma Therapeutics (United States)

1. Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models

   Stefano Pierini, Rashid Gabbasov, Maria Cecília Oliveira-Nunes +28

   Maqola20254 iqtibos

   ABIABI:AkademIndex/2026.other.479137